Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Exploring the potential public health benefits of universal influenza vaccine.

DePasse JV, Nowalk MP, Smith KJ, Raviotta JM, Shim E, Zimmerman RK, Brown ST.

Hum Vaccin Immunother. 2019 Jun 18:1-8. doi: 10.1080/21645515.2019.1619406. [Epub ahead of print]

PMID:
31091166
2.

Compressed Influenza Vaccination in U.S. Older Adults: A Decision Analysis.

Smith KJ, France G, Nowalk MP, Raviotta JM, DePasse J, Wateska A, Shim E, Zimmerman RK.

Am J Prev Med. 2019 Apr;56(4):e135-e141. doi: 10.1016/j.amepre.2018.11.015. Epub 2019 Feb 14.

PMID:
30772149
3.

Potential Cost-Effectiveness of a Universal Influenza Vaccine in Older Adults.

France G, Wateska AR, Nowalk MP, DePasse J, Raviotta JM, Shim E, Zimmerman RK, Smith KJ.

Innov Aging. 2018 Dec 14;2(3):igy035. doi: 10.1093/geroni/igy035. eCollection 2018 Sep.

4.

Impact of seasonal influenza vaccination in the presence of vaccine interference.

Shim E, Smith KJ, Nowalk MP, Raviotta JM, Brown ST, DePasse J, Zimmerman RK.

Vaccine. 2018 Feb 1;36(6):853-858. doi: 10.1016/j.vaccine.2017.12.067. Epub 2018 Jan 9.

5.

Using the 4 Pillars to increase vaccination among high-risk adults: who benefits?

Nowalk MP, Moehling KK, Zhang S, Raviotta JM, Zimmerman RK, Lin CJ.

Am J Manag Care. 2017 Nov;23(11):651-655.

6.

Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination.

Zimmerman RK, Raviotta JM, Nowalk MP, Moehling KK, Reis EC, Humiston SG, Lin CJ.

Vaccine. 2017 Oct 27;35(45):6180-6186. doi: 10.1016/j.vaccine.2017.09.039. Epub 2017 Sep 22.

7.

Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults.

Raviotta JM, Smith KJ, DePasse J, Brown ST, Shim E, Nowalk MP, Wateska A, France GS, Zimmerman RK.

Vaccine. 2017 Oct 9;35(42):5708-5713. doi: 10.1016/j.vaccine.2017.07.069. Epub 2017 Sep 7.

8.

Does cost-effectiveness of influenza vaccine choice vary across the U.S.? An agent-based modeling study.

DePasse JV, Nowalk MP, Smith KJ, Raviotta JM, Shim E, Zimmerman RK, Brown ST.

Vaccine. 2017 Jul 13;35(32):3974-3981. doi: 10.1016/j.vaccine.2017.05.093. Epub 2017 Jun 9.

9.

Reply to: Estimating the Full Value of High-Dose Influenza Vaccine.

Raviotta JM, Smith KJ, DePasse J, Brown ST, Shim E, Nowalk MP, Zimmerman RK.

J Am Geriatr Soc. 2017 Sep;65(9):2111-2112. doi: 10.1111/jgs.14976. Epub 2017 Jun 6. No abstract available.

10.

Potential Consequences of Not Using Live Attenuated Influenza Vaccine.

Smith KJ, Nowalk MP, Wateska A, Brown ST, DePasse JV, Raviotta JM, Shim E, Zimmerman RK.

Am J Prev Med. 2017 Oct;53(4):500-503. doi: 10.1016/j.amepre.2017.02.019. Epub 2017 Apr 18.

11.

Does Choice of Influenza Vaccine Type Change Disease Burden and Cost-Effectiveness in the United States? An Agent-Based Modeling Study.

DePasse JV, Smith KJ, Raviotta JM, Shim E, Nowalk MP, Zimmerman RK, Brown ST.

Am J Epidemiol. 2017 May 1;185(9):822-831. doi: 10.1093/aje/kww229.

12.

Using a Mixed Methods Approach to Examine Practice Characteristics Associated With Implementation of an Adult Immunization Intervention Using the 4 Pillars Practice Transformation Program.

Hawk M, Nowalk MP, Moehling KK, Pavlik V, Raviotta JM, Brown AE, Zimmerman RK, Ricci EM.

J Healthc Qual. 2017 May/Jun;39(3):153-167. doi: 10.1097/JHQ.0000000000000071.

13.

Improving adolescent HPV vaccination in a randomized controlled cluster trial using the 4 Pillars™ practice Transformation Program.

Zimmerman RK, Moehling KK, Lin CJ, Zhang S, Raviotta JM, Reis EC, Humiston SG, Nowalk MP.

Vaccine. 2017 Jan 3;35(1):109-117. doi: 10.1016/j.vaccine.2016.11.018. Epub 2016 Nov 18.

14.

Using the 4 pillars™ practice transformation program to increase adult influenza vaccination and reduce missed opportunities in a randomized cluster trial.

Lin CJ, Nowalk MP, Pavlik VN, Brown AE, Zhang S, Raviotta JM, Moehling KK, Hawk M, Ricci EM, Middleton DB, Patel S, South-Paul JE, Zimmerman RK.

BMC Infect Dis. 2016 Nov 3;16(1):623.

15.

Cost-Effectiveness and Public Health Effect of Influenza Vaccine Strategies for U.S. Elderly Adults.

Raviotta JM, Smith KJ, DePasse J, Brown ST, Shim E, Nowalk MP, Zimmerman RK.

J Am Geriatr Soc. 2016 Oct;64(10):2126-2131. doi: 10.1111/jgs.14323. Epub 2016 Oct 6.

16.

Using the 4 Pillars Practice Transformation Program to Increase Pneumococcal Immunizations for Older Adults: A Cluster-Randomized Trial.

Zimmerman RK, Brown AE, Pavlik VN, Moehling KK, Raviotta JM, Lin CJ, Zhang S, Hawk M, Kyle S, Patel S, Ahmed F, Nowalk MP.

J Am Geriatr Soc. 2017 Jan;65(1):114-122. doi: 10.1111/jgs.14451. Epub 2016 Oct 18.

17.

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

Zimmerman RK, Nowalk MP, Chung J, Jackson ML, Jackson LA, Petrie JG, Monto AS, McLean HQ, Belongia EA, Gaglani M, Murthy K, Fry AM, Flannery B; US Flu VE Investigators; U.S. Flu VE Investigators.

Clin Infect Dis. 2016 Dec 15;63(12):1564-1573. Epub 2016 Oct 4.

18.

Using the 4 Pillars™ Practice Transformation Program to increase adult Tdap immunization in a randomized controlled cluster trial.

Nowalk MP, Lin CJ, Pavlik VN, Brown AE, Zhang S, Moehling KK, Raviotta JM, South-Paul JE, Hawk M, Ricci EM, Middleton DB, Patel SA, Ahmed F, Zimmerman RK.

Vaccine. 2016 Sep 22;34(41):5026-5033. doi: 10.1016/j.vaccine.2016.07.053. Epub 2016 Aug 26.

19.

Cost Effectiveness of Influenza Vaccine for U.S. Children: Live Attenuated and Inactivated Influenza Vaccine.

Shim E, Brown ST, DePasse J, Nowalk MP, Raviotta JM, Smith KJ, Zimmerman RK.

Am J Prev Med. 2016 Sep;51(3):309-17. doi: 10.1016/j.amepre.2016.02.027. Epub 2016 Apr 11.

20.

Cost Effectiveness of Influenza Vaccine Choices in Children Aged 2-8 Years in the U.S.

Smith KJ, Raviotta JM, DePasse JV, Brown ST, Shim E, Patricia Nowalk M, Zimmerman RK.

Am J Prev Med. 2016 May;50(5):600-608. doi: 10.1016/j.amepre.2015.12.010. Epub 2016 Feb 8.

Supplemental Content

Loading ...
Support Center